» Articles » PMID: 35292074

Effectiveness of Herb-partitioned Moxibustion on the Navel for Pregnancy Outcomes in Patients with Recurrent Implantation Failure Undergoing in Vitro Fertilization and Embryo Transfer: a Study Protocol for a Randomized Controlled Trial

Overview
Journal Trials
Publisher Biomed Central
Date 2022 Mar 16
PMID 35292074
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Recurrent implantation failure (RIF) in the majority of patients undergoing in vitro fertilization and embryo transfer (IVF-ET) is caused by various factors such as maternal age, embryo quality, endometrial receptivity (ER), and immunity. The incidence of RIF is usually between 5 and 10%. Previous studies have shown that herb-partitioned moxibustion on the navel is one of the treatment methods of acupuncture with a positive effect on pregnancy. However, its application in the treatment of RIF has not been reported. Therefore, this study aims to evaluate the effectiveness and safeness of herb-partitioned moxibustion on the navel in improving the outcome of frozen embryo transfer (FET) in patients with RIF.

Methods: This study conducts a randomized controlled trial (RCT). It is planned to recruit 210 patients undergoing RIF for FET from Affiliated Hospital of Shandong University of Traditional Chinese Medicine and randomly divide them into the treatment group and the control group in a ratio of 1:1. The patient of the treatment group will be treated with herb-partitioned moxibustion on the navel once a week for three consecutive menstrual cycles. No intervention will be used in the control group for 3 menstrual cycles. In the fourth menstrual cycle, all patients will undergo artificial cycle to prepare the endometrium for FET. The pregnancy outcomes will be recorded after a 3-month follow-up. Primary outcome will be assessed as the ongoing pregnancy rate compared with the control group. Secondary outcomes include the endometrial type, resistance index (RI), pulsatility index (PI) of the bilateral uterine artery, endometrial blood flow, serum estradiol (E), progesterone (P), biochemical pregnancy rate, implantation rate, and clinical pregnancy rate.

Discussion: If the results show that the herb-partitioned moxibustion on the navel can improve IVF-ET outcomes in patients with RIF, it will be recommended in clinical practice.

Trial Registration: Chinese Clinical Trial Registry (ChiCTR) ChiCTR2100043954 . Registered on 8 July 2021.

Citing Articles

Efficacy and safety of Shen Que (RN8) moxibustion on reproductive outcomes in unexpected poor ovarian responders: a randomized controlled trial.

Song J, Sun Z, Ma Y J Ovarian Res. 2024; 17(1):177.

PMID: 39210342 PMC: 11363657. DOI: 10.1186/s13048-024-01493-2.


Acupuncture combined with gonadotropin-releasing hormone agonists improves endometrial receptivity and pregnancy outcome in patients with recurrent implantation failure of in vitro fertilization-embryo transfer.

Yang J, Lu Y, Zhang Y, Zhou C, Liang Q, Liang T J Assist Reprod Genet. 2024; 41(8):2185-2192.

PMID: 38847932 PMC: 11339202. DOI: 10.1007/s10815-024-03140-7.

References
1.
Cimadomo D, Craciunas L, Vermeulen N, Vomstein K, Toth B . Definition, diagnostic and therapeutic options in recurrent implantation failure: an international survey of clinicians and embryologists. Hum Reprod. 2020; 36(2):305-317. DOI: 10.1093/humrep/deaa317. View

2.
Han M, Cao Y, Zhou W, Zhou M, Zhou X, Zhang D . Increased expression of HMGB1 in the implantation phase endometrium is related to recurrent implantation failure. Mol Biol Rep. 2022; 49(3):1701-1710. DOI: 10.1007/s11033-021-06979-6. View

3.
Canella P, Barini R, de Oliveira Carvalho P, Razolli D . Lipid emulsion therapy in women with recurrent pregnancy loss and repeated implantation failure: The role of abnormal natural killer cell activity. J Cell Mol Med. 2021; 25(5):2290-2296. PMC: 7933936. DOI: 10.1111/jcmm.16257. View

4.
Sheikhansari G, Pourmoghadam Z, Danaii S, Mehdizadeh A, Yousefi M . Etiology and management of recurrent implantation failure: A focus on intra-uterine PBMC-therapy for RIF. J Reprod Immunol. 2020; 139:103121. DOI: 10.1016/j.jri.2020.103121. View

5.
Kolanska K, Bendifallah S, Cohen J, Placais L, Selleret L, Johanet C . Unexplained recurrent implantation failures: Predictive factors of pregnancy and therapeutic management from a French multicentre study. J Reprod Immunol. 2021; 145:103313. DOI: 10.1016/j.jri.2021.103313. View